The Journal of Hematology and Oncology focuses on the therapeutic landscape of various cancers, with a strong emphasis on novel treatment modalities and their clinical application. Recent articles highlight advancements in immunotherapies such as chimeric antigen receptor (CAR) T-cell and CAR-macrophage therapies, bispecific antibodies, and antibody-drug conjugates (ADCs). The journal also covers research on targeted therapies, including CDK4/6 inhibitors and agents targeting specific molecular pathways, as well as the role of biomarkers like circulating tumor DNA (ctDNA) in guiding treatment decisions. Investigations into the tumor microenvironment and its modulation by various therapeutic strategies are also a recurring theme.
CAR-T cell therapy researchAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchHematopoietic Stem Cell TransplantationCancer-related molecular mechanisms researchImmunotherapy and Immune Responses